<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"><channel><title>selegiline transdermal</title><link>http://www.unboundmedicine.com/medline/ebm/research/selegiline_transdermal</link><description>Unbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.</description><language>en-us</language><copyright>Unbound Medicine, Inc.</copyright><item><title>Selegiline and oxidative stress in HIV-associated cognitive impairment.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19890073/full_citation/Selegiline_and_oxidative_stress_in_HIV_associated_cognitive_impairment_</link><description>Schifitto G, Yiannoutsos CT, Ernst T, et al. <br/><span class="title">Selegiline and oxidative stress in HIV-associated cognitive impairment. [JOURNAL ARTICLE]</span><br/><span class="source" title="Neurology">Neurology 2009 Nov 4.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19890073/abstract/Selegiline_and_oxidative_stress_in_HIV_associated_cognitive_impairment_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19890073/full_citation/Selegiline_and_oxidative_stress_in_HIV_associated_cognitive_impairment_">Full Citation</a> | <a href="http://www.neurology.org/cgi/pmidlookup%3fview=long%26amp;pmid=19890073">Publisher Full Text</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19890073/Selegiline_and_oxidative_stress_in_HIV_associated_cognitive_impairment_">Find Related Articles</a> </description></item><item><title>A Phase 1 Trial of pharmacologic interactions between transdermal selegiline and a 4-hour cocaine infusion.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19646280/full_citation/A_Phase_1_Trial_of_pharmacologic_interactions_between_transdermal_selegiline_and_a_4_hour_cocaine_infusion_</link><description>Harris DS, Everhart T, Jacob P, et al. <br/><span class="title">A Phase 1 Trial of pharmacologic interactions between transdermal selegiline and a 4-hour cocaine infusion. [JOURNAL ARTICLE]</span><br/><span class="source" title="BMC clinical pharmacology">BMC Clin Pharmacol 2009 Aug 1; 9(1):13.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19646280/abstract/A_Phase_1_Trial_of_pharmacologic_interactions_between_transdermal_selegiline_and_a_4_hour_cocaine_infusion_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19646280/full_citation/A_Phase_1_Trial_of_pharmacologic_interactions_between_transdermal_selegiline_and_a_4_hour_cocaine_infusion_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19646280/A_Phase_1_Trial_of_pharmacologic_interactions_between_transdermal_selegiline_and_a_4_hour_cocaine_infusion_">Find Related Articles</a> </description></item><item><title>Transdermal permeation of selegiline from hydrogel-membrane drug delivery systems.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19563870/full_citation/Transdermal_permeation_of_selegiline_from_hydrogel_membrane_drug_delivery_systems_</link><description>Fang JY, Hung CF, Chi CH, et al. <br/><span class="title">Transdermal permeation of selegiline from hydrogel-membrane drug delivery systems. [JOURNAL ARTICLE]</span><br/><span class="source" title="International journal of pharmaceutics">Int J Pharm 2009 Jun 26.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19563870/abstract/Transdermal_permeation_of_selegiline_from_hydrogel_membrane_drug_delivery_systems_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19563870/full_citation/Transdermal_permeation_of_selegiline_from_hydrogel_membrane_drug_delivery_systems_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19563870/Transdermal_permeation_of_selegiline_from_hydrogel_membrane_drug_delivery_systems_">Find Related Articles</a> </description></item><item><title>Selegiline transdermal system: a novel treatment option for major depressive disorder.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19527191/full_citation/Selegiline_transdermal_system:_a_novel_treatment_option_for_major_depressive_disorder_</link><description>Nandagopal JJ, DelBello MP <br/><span class="title">Selegiline transdermal system: a novel treatment option for major depressive disorder. [Journal Article]</span><br/><span class="source" title="Expert opinion on pharmacotherapy">Expert Opin Pharmacother 2009 Jul; 10(10):1665-73.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19527191/abstract/Selegiline_transdermal_system:_a_novel_treatment_option_for_major_depressive_disorder_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19527191/full_citation/Selegiline_transdermal_system:_a_novel_treatment_option_for_major_depressive_disorder_">Full Citation</a> | <a href="http://www.informapharmascience.com/doi/abs/10.1517/14656560903048942">Publisher Full Text</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19527191/Selegiline_transdermal_system:_a_novel_treatment_option_for_major_depressive_disorder_">Find Related Articles</a> </description></item><item><title>A case report of high-dose transdermal selegiline in the treatment of major depressive disorder.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19239833/full_citation/A_case_report_of_high_dose_transdermal_selegiline_in_the_treatment_of_major_depressive_disorder_</link><description>Ashton AK <br/><span class="title">A case report of high-dose transdermal selegiline in the treatment of major depressive disorder. [Journal Article]</span><br/><span class="source" title="Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists">Ann Clin Psychiatry 2009 Jan-Mar; 21(1):51-2.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19239833/full_citation/A_case_report_of_high_dose_transdermal_selegiline_in_the_treatment_of_major_depressive_disorder_">Full Citation</a></description></item><item><title>The selegiline transdermal system (emsam): a therapeutic option for the treatment of major depressive disorder.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19750165/full_citation/The_selegiline_transdermal_system__emsam_:_a_therapeutic_option_for_the_treatment_of_major_depressive_disorder_</link><description>Jessen L, Kovalick LJ, Azzaro AJ <br/><span class="title">The selegiline transdermal system (emsam): a therapeutic option for the treatment of major depressive disorder. [Journal Article]</span><br/><span class="source" title="P &amp; T : a peer-reviewed journal for formulary management">P T 2008 Apr; 33(4):212-46.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19750165/abstract/The_selegiline_transdermal_system__emsam_:_a_therapeutic_option_for_the_treatment_of_major_depressive_disorder_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19750165/full_citation/The_selegiline_transdermal_system__emsam_:_a_therapeutic_option_for_the_treatment_of_major_depressive_disorder_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19750165/The_selegiline_transdermal_system__emsam_:_a_therapeutic_option_for_the_treatment_of_major_depressive_disorder_">Find Related Articles</a> </description></item><item><title>A review of the literature on the selegiline transdermal system: an effective and well-tolerated monoamine oxidase inhibitor for the treatment of depression.</title><link>http://www.unboundmedicine.com/medline/ebm/record/18311418/full_citation/A_review_of_the_literature_on_the_selegiline_transdermal_system:_an_effective_and_well_tolerated_monoamine_oxidase_inhibitor_for_the_treatment_of_depression_</link><description>Culpepper L, Kovalick LJ <br/><span class="title">A review of the literature on the selegiline transdermal system: an effective and well-tolerated monoamine oxidase inhibitor for the treatment of depression. [Journal Article]</span><br/><span class="source" title="Primary care companion to the Journal of clinical psychiatry">Prim Care Companion J Clin Psychiatry 2008; 10(1):25-30.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/18311418/abstract/A_review_of_the_literature_on_the_selegiline_transdermal_system:_an_effective_and_well_tolerated_monoamine_oxidase_inhibitor_for_the_treatment_of_depression_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/18311418/full_citation/A_review_of_the_literature_on_the_selegiline_transdermal_system:_an_effective_and_well_tolerated_monoamine_oxidase_inhibitor_for_the_treatment_of_depression_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/18311418/A_review_of_the_literature_on_the_selegiline_transdermal_system:_an_effective_and_well_tolerated_monoamine_oxidase_inhibitor_for_the_treatment_of_depression_">Find Related Articles</a> </description></item><item><title>Transdermal selegiline: new opportunity for managing depression.</title><link>http://www.unboundmedicine.com/medline/ebm/record/18303066/full_citation/Transdermal_selegiline:_new_opportunity_for_managing_depression_</link><description>Tobe EH <br/><span class="title">Transdermal selegiline: new opportunity for managing depression. [Letter]</span><br/><span class="source" title="The Journal of the American Osteopathic Association">J Am Osteopath Assoc 2008 Feb; 108(2):85-6.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/18303066/full_citation/Transdermal_selegiline:_new_opportunity_for_managing_depression_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/18303066/Transdermal_selegiline:_new_opportunity_for_managing_depression_">Find Related Articles</a> </description></item><item><title>Symptoms of sexual dysfunction in patients treated for major depressive disorder: a meta-analysis comparing selegiline transdermal system and placebo using a patient-rated scale.</title><link>http://www.unboundmedicine.com/medline/ebm/record/18162016/full_citation/Symptoms_of_sexual_dysfunction_in_patients_treated_for_major_depressive_disorder:_a_meta_analysis_comparing_selegiline_transdermal_system_and_placebo_using_a_patient_rated_scale_</link><description>Clayton AH, Campbell BJ, Favit A, et al. <br/><span class="title">Symptoms of sexual dysfunction in patients treated for major depressive disorder: a meta-analysis comparing selegiline transdermal system and placebo using a patient-rated scale. [Comparative Study, Journal Article, Meta-Analysis]</span><br/><span class="source" title="The Journal of clinical psychiatry">J Clin Psychiatry 2007 Dec; 68(12):1860-6.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/18162016/abstract/Symptoms_of_sexual_dysfunction_in_patients_treated_for_major_depressive_disorder:_a_meta_analysis_comparing_selegiline_transdermal_system_and_placebo_using_a_patient_rated_scale_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/18162016/full_citation/Symptoms_of_sexual_dysfunction_in_patients_treated_for_major_depressive_disorder:_a_meta_analysis_comparing_selegiline_transdermal_system_and_placebo_using_a_patient_rated_scale_">Full Citation</a> | <a href="http://article.psychiatrist.com/%3fContentType=START%26amp;ID=10003380">Publisher Full Text</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/18162016/Symptoms_of_sexual_dysfunction_in_patients_treated_for_major_depressive_disorder:_a_meta_analysis_comparing_selegiline_transdermal_system_and_placebo_using_a_patient_rated_scale_">Find Related Articles</a> </description></item><item><title>Selegiline Transdermal System (STS) for HIV-Associated Cognitive Impairment: Open-Label Report of ACTG 5090.</title><link>http://www.unboundmedicine.com/medline/ebm/record/18042509/full_citation/Selegiline_Transdermal_System__STS__for_HIV_Associated_Cognitive_Impairment:_Open_Label_Report_of_ACTG_5090_</link><description>Evans SR, Yeh TM, Sacktor N, et al. <br/><span class="title">Selegiline Transdermal System (STS) for HIV-Associated Cognitive Impairment: Open-Label Report of ACTG 5090. [Journal Article]</span><br/><span class="source" title="HIV clinical trials">HIV Clin Trials 2007 Nov-Dec; 8(6):437-46.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/18042509/abstract/Selegiline_Transdermal_System__STS__for_HIV_Associated_Cognitive_Impairment:_Open_Label_Report_of_ACTG_5090_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/18042509/full_citation/Selegiline_Transdermal_System__STS__for_HIV_Associated_Cognitive_Impairment:_Open_Label_Report_of_ACTG_5090_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/18042509/Selegiline_Transdermal_System__STS__for_HIV_Associated_Cognitive_Impairment:_Open_Label_Report_of_ACTG_5090_">Find Related Articles</a> </description></item></channel></rss>